Observational studyMedicine2019

Solvent-based paclitaxel or nab-paclitaxel for heavily treated relapsed/refractory small cell lung cancer: Retrospective single-institution observational study.

Keiji Sugiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.